These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 9106171)

  • 21. Phase Ib trial of granulocyte-macrophage colony-stimulating factor combined with murine monoclonal antibody R24 in patients with metastatic melanoma.
    Chachoua A; Oratz R; Liebes L; Alter RS; Felice A; Peace D; Vilcek J; Blum RH
    J Immunother Emphasis Tumor Immunol; 1994 Aug; 16(2):132-41. PubMed ID: 7804528
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Granulocyte macrophage - colony stimulating factor (GM-CSF) significantly enhances articular cartilage repair potential by microfracture.
    Truong MD; Choi BH; Kim YJ; Kim MS; Min BH
    Osteoarthritis Cartilage; 2017 Aug; 25(8):1345-1352. PubMed ID: 28284999
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sensitivity of dendritic cells to NK-mediated lysis depends on the inflammatory environment and is modulated by CD54/CD226-driven interactions.
    Smith LE; Olszewski MA; Georgoudaki AM; Wagner AK; Hägglöf T; Karlsson MC; Dominguez-Villar M; Garcia-Cozar F; Mueller S; Ravens I; Bernhardt G; Chambers BJ
    J Leukoc Biol; 2016 Oct; 100(4):781-789. PubMed ID: 27034402
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prestimulation of monocytes by the cytokines GM-CSF or IL-2 enhances the antibody dependent cellular cytotoxicity of monoclonal antibody 17-1A.
    Flieger D; Spengler U; Beier I; Sauerbruch T; Schmidt-Wolf IG
    Z Gastroenterol; 2000 Aug; 38(8):615-22. PubMed ID: 11031784
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human granulocyte-macrophage colony-stimulating factor (hGM-CSF)-dependent in vitro and in vivo proliferation and differentiation of all hematopoietic progenitor cells in hGM-CSF receptor transgenic mice.
    Nishijima I; Watanabe S; Nakahata T; Arai K
    J Allergy Clin Immunol; 1997 Dec; 100(6 Pt 2):S79-86. PubMed ID: 9440551
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Induction of granulocyte-macrophage colony-stimulating factor (GM-CSF) and granulocyte colony-stimulating factor (G-CSF) expression in bone marrow and fractionated marrow cell populations by interleukin 3 (IL-3): IL-3-mediated positive feedback mechanisms of granulopoiesis.
    Tsuji T; Sugimoto K; Yanai T; Takashita E; Mori KJ
    Growth Factors; 1994; 11(1):71-9. PubMed ID: 7530467
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stem cell factor augments tumor necrosis factor-granulocyte-macrophage colony-stimulating factor-mediated dendritic cell hematopoiesis.
    Santiago-Schwarz F; Rappa DA; Laky K; Carsons SE
    Stem Cells; 1995 Mar; 13(2):186-97. PubMed ID: 7540472
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Granulocyte-macrophage colony-stimulating factor (GM-CSF) counteracts the inhibiting effect of monocytes on natural killer (NK) cells.
    van den Bosch G; Preijers F; Vreugdenhil A; Hendriks J; Maas F; De Witte T
    Clin Exp Immunol; 1995 Sep; 101(3):515-20. PubMed ID: 7664499
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The boosting effect of co-transduction with cytokine genes on cancer vaccine therapy using genetically modified dendritic cells expressing tumor-associated antigen.
    Ojima T; Iwahashi M; Nakamura M; Matsuda K; Naka T; Nakamori M; Ueda K; Ishida K; Yamaue H
    Int J Oncol; 2006 Apr; 28(4):947-53. PubMed ID: 16525645
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Granulocyte-macrophage colony-stimulating factor elicits bone marrow-derived cells that promote efficient colonic mucosal healing.
    Bernasconi E; Favre L; Maillard MH; Bachmann D; Pythoud C; Bouzourene H; Croze E; Velichko S; Parkinson J; Michetti P; Velin D
    Inflamm Bowel Dis; 2010 Mar; 16(3):428-41. PubMed ID: 19639560
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Monocyte-mediated lysis of acute myeloid leukemia cells in the presence of the bispecific antibody 251 x 22 (anti-CD33 x anti-CD64).
    Chen J; Zhou JH; Ball ED
    Clin Cancer Res; 1995 Nov; 1(11):1319-25. PubMed ID: 9815927
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The human ortholog of granulocyte macrophage colony-stimulating factor and interleukin-2 fusion protein induces potent ex vivo natural killer cell activation and maturation.
    Penafuerte C; Bautista-Lopez N; Boulassel MR; Routy JP; Galipeau J
    Cancer Res; 2009 Dec; 69(23):9020-8. PubMed ID: 19920194
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enhancement of natural killer cell-mediated cytotoxicity by coexpression of GM-CSF/B70 in hepatoma.
    Kim KY; Kang MA; Nam MJ
    Cancer Lett; 2001 May; 166(1):33-40. PubMed ID: 11295284
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Therapy of established tumour with a hybrid cellular vaccine generated by using granulocyte-macrophage colony-stimulating factor genetically modified dendritic cells.
    Cao X; Zhang W; Wang J; Zhang M; Huang X; Hamada H; Chen W
    Immunology; 1999 Aug; 97(4):616-25. PubMed ID: 10457215
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impaired cutaneous wound healing in granulocyte/macrophage colony-stimulating factor knockout mice.
    Fang Y; Gong SJ; Xu YH; Hambly BD; Bao S
    Br J Dermatol; 2007 Sep; 157(3):458-65. PubMed ID: 17553038
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development of multipotential haemopoietic stem cells to neutrophils is associated with increased expression of receptors for granulocyte macrophage colony-stimulating factor: altered biological responses to GM-CSF during development.
    Heyworth CM; Hampson J; Dexter TM; Walker F; Burgess AW; Kan O; Cook N; Vallance SJ; Whetton AD
    Growth Factors; 1991; 5(2):87-98. PubMed ID: 1837466
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Future uses of granulocyte-macrophage colony-stimulating factor (GM-CSF).
    Jones TC
    Stem Cells; 1994; 12 Suppl 1():229-39; discussion 239-40. PubMed ID: 7696962
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hematopoietic recovery following high-dose combined alkylating-agent chemotherapy and autologous bone marrow support in patients in phase-I clinical trials of colony-stimulating factors: G-CSF, GM-CSF, IL-1, IL-2, M-CSF.
    Laughlin MJ; Kirkpatrick G; Sabiston N; Peters W; Kurtzberg J
    Ann Hematol; 1993 Dec; 67(6):267-76. PubMed ID: 7506580
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Practical Application of Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) in Patients with Wounds.
    Brem H; Howell R; Criscitelli T; Senderowicz A; Siegart N; Gorenstein S; Gillette B
    Surg Technol Int; 2018 Jun; 32():61-66. PubMed ID: 29611156
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Granulocyte-macrophage colony-stimulating factor (GM-CSF) and T-cell responses: what we do and don't know.
    Shi Y; Liu CH; Roberts AI; Das J; Xu G; Ren G; Zhang Y; Zhang L; Yuan ZR; Tan HS; Das G; Devadas S
    Cell Res; 2006 Feb; 16(2):126-33. PubMed ID: 16474424
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.